CO-KRISTALL

European patent · EP3412667 · In force

Register entry

Publication number
EP3412667
Application number
EP17747415
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 31, 2017
Published
Dec 12, 2018
Granted
Nov 3, 2021
Protection ends at the latest
Jan 30, 2037
Next annual fee due
Jan 31, 2027
IPC classes
A61K 31/4545 (2006.01)
C07D 471/04 (2006.01)
A61P 35/00 (2006.01)
Priority
JP 2016017099 01.02.2016
PCT application
PCT/JP2017/003453 31.01.2017
PCT publication
WO2017/135259 10.08.2017
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Sep 14, 2022

    Change

    Published in Swissreg on 14.09.2022

  6. Jan 25, 2022

    Agent entered

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 25.01.2022

  7. Nov 3, 2021

    Granted

    Published in Swissreg on 03.11.2021

Parties

Holder

Takeda Pharmaceutical Company Limited

1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP

Agent

Bovard AG

BOVARD AG

Patent- und Markenanwälte Optingenstrasse 16, 3013 Bern

Inventor

IWATA, Kentaro

Fujisawa-shi Kanagawa 251-0012, JP

IKEDA, Yukihiro

Fujisawa-shi Kanagawa 251-0012, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.